Connect with us

Lithane (lithium carbonate)

Lithium Carbonate (or LITHANE®) is mainly prescribed to treat bipolar disorder and major depressive disorder.

Status: ACTIVE

Class: Mood Stabilizer

FDA Approval: 1970

Dosage Forms: 150 mg, 300 mg, 600 mg

Biological Half-life: 24-36 hours

Side Effects: Dizziness, dry mouth, blurry vision, nausea, vomiting, confusion, constipation, renal toxicity, increased thirst, increased urination, vertigo, weight gain, leukocytosis, hypothyroidism, acne, hair loss, movement problems

Serious Risks: Increased risk of hypothyroidism and diabetes insipidus

Routes of Administration: Oral, Parenteral

Pregnancy Category: D (US)


Twitter Feed

Researchers found insomnia may increase risk of mood disorder in teens #mentalhealth @PittTweet

Can Tylenol provide relief for social media anxiety? #FOMO #socialanxiety #cyberpsychology

High-intensity exercise may hinder symptoms of Parkinson's, study finds #fitness #Parkinsons